Cours Boston Therapeutics, Inc. Other OTC
Actions
BTHE
US1011501004
Equipement et technologie médicale avancés
CA 2021 | 142 k 129 k | CA 2022 | 15,45 k 14,07 k | Capitalisation | 9,32 M 8,48 M |
---|---|---|---|---|---|
Résultat net 2021 | -9 M -8,19 M | Résultat net 2022 | -12 M -10,92 M | VE / CA 2021 | 149 x |
Dette nette 2021 | 4,52 M 4,11 M | Dette nette 2022 | 11,39 M 10,37 M | VE / CA 2022 | 1 340 x |
PER 2021 |
-1,75
x | PER 2022 |
-0,62
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 42,05% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19/01/23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+4,84% | 32,47 Md | |
+16,51% | 7,45 Md | |
+23,49% | 3,89 Md | |
-15,68% | 3,17 Md | |
-27,35% | 1,28 Md | |
-33,58% | 1,09 Md | |
-33,74% | 902 M | |
+0,92% | 893 M | |
-25,64% | 857 M |